Related Experiment Video

Updated: Jul 14, 2026

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

Bacterial infection-related morbidity and mortality in cirrhosis

Leonidas Christou1, Georgios Pappas, Matthew E Falagas

  • 1Division of Internal Medicine of the Medical School at the University of Ioannina, Ioannina, Greece.

The American Journal of Gastroenterology
|May 19, 2007
PubMed
Abstract

Insights

Cirrhotic patients face significant risks from bacterial infections beyond spontaneous bacterial peritonitis. More research is needed on infection prevention and treatment strategies for this vulnerable population.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Bacterial infections contribute significantly to morbidity and mortality in patients with cirrhosis.
  • While spontaneous bacterial peritonitis is well-studied, other infections in cirrhosis remain under-researched.

Purpose of the Study:

  • To evaluate existing medical data on infectious risks in cirrhotic patients.
  • To review preventive and treatment strategies for infections in this population.

Main Methods:

  • Comprehensive literature search of MEDLINE.
  • Keywords focused on cirrhosis-related immunodeficiency, infection incidence, and specific pathogens.
  • Analysis of preventive strategies and therapeutic interventions.

Main Results:

  • Cirrhosis-induced immunodeficiency is complex and difficult to reverse with single interventions.
  • Epidemiological data on specific infections and risk factors are limited, with Child-Pugh stage C being a frequent characteristic.
  • Common pathogens (Staphylococcus aureus, Streptococcus pneumoniae, Mycobacterium tuberculosis) and uncommon microbes pose significant risks, some unrecognized.

Conclusions:

  • Further data are required on the efficacy of pneumococcal vaccination in cirrhotic patients.
  • The overall burden of tuberculosis and the incidence of specific infections like endocarditis need more investigation.
  • Enhanced understanding of infection risks is crucial for improving survival in cirrhotic patients.

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...